+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Global Tissue Diagnostics Market by Product (Accessories, Consumables, Instruments), Technology (Digital Pathology & Workflow, Immunohistochemistry, In Situ Hybridization), Indications, End-User - Forecast 2024-2030

  • PDF Icon

    Report

  • 194 Pages
  • May 2024
  • Region: Global
  • 360iResearch™
  • ID: 4989888
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Tissue Diagnostics Market size was estimated at USD 8.30 billion in 2023, USD 8.94 billion in 2024, and is expected to grow at a CAGR of 7.76% to reach USD 14.02 billion by 2030.

Tissue diagnostics is a medical field that involves examining and analyzing tissue samples from a patient's body to diagnose diseases or conditions. It is crucial in diagnosing and treating various medical conditions, including cancer and other tissue-related diseases. Tissue diagnostics has applications across several clinical areas and is crucial in personalized medicine for assisting in early disease detection. An increase in global cancer prevalence rates and an aging population drive the demand for tissue diagnostic services. Advancements in genomics have led to the identification of numerous biomarkers associated with diseases, which have further spurred the need for accurate diagnostic tests.

However, high costs associated with diagnostic instruments and services might impede their adoption by small-scale healthcare providers or low-resource settings. The lack of skilled professionals capable of interpreting complex test results and insufficient pathologists worldwide could hinder market expansion. Technological advances such as artificial intelligence (AI) integration with digital pathology have opened up new opportunities for the market players. AI-based algorithms can aid pathologists in detecting subtle morphological changes within tissues that may be easily overlooked. Additionally, growing investments from governments and private organizations towards healthcare infrastructure are expected to provide more avenues for growth in this sector.

Regional Insights

The Americas has a significant landscape in the tissue diagnostics market owing to advanced healthcare infrastructure and extensive research funding by the key manufacturers in the development of diagnostics tests. The manufacturers in the region have observed numerous patents issued by the FDA for innovations in tissue diagnostics technology. The EMEA region has observed a developing landscape in the tissue diagnostics market due to significant investments made by the government to support research initiatives for early diagnosis of diseases such as cancer to improve diagnostic techniques. Government standards and regulations on the safety and quality of tissue diagnostics consumables have also contributed to the market growth in the region.

South Africa is a hub for innovation within the African continent, with several ongoing research initiatives focused on developing efficient diagnostic tools that cater to local disease prevalence patterns. APAC region in the market has a developing growth due to technological advancements, investment in research and development of state-of-the-art tissue diagnostic technologies, increasing cancer incidence, and government initiatives encouraging local manufacturing of diagnostic equipment, fostering innovation within the country's tissue diagnostics industry.

Market Trends by Segment

  • Product: Proliferating use of tissue-processing systems for efficient processing and analyzing diagnosing tissue samples
  • Technology: Adoption of digital pathology technology for the management of digitized histological samples through computer technology
  • Indications: Exponential use of tissue diagnostics in the detection and characterization of numerous cancer types
  • End-User: Significant utilization of tissue diagnostics in clinical pathology laboratories to improve patient care quality

Industry Insights

  • Market Dynamics
  • Market Disruption Analysis
  • Porter’s Five Forces Analysis
  • Value Chain & Critical Path Analysis
  • Pricing Analysis
  • Technology Analysis
  • Patent Analysis
  • Trade Analysis
  • Regulatory Framework Analysis
  • FPNV Positioning Matrix
  • Market Share Analysis
  • Strategy Analysis and Recommendations

Recent Developments

PathAI Announces Expansion of BioPharma Lab to Provide End-to-End Central Pathology and Histology Services

Tissue Diagnostics PathAI, an AI-powered pathology, has expanded its BioPharma Laboratory Services. PathAI offers a wide range of services for prospective clinical trials in oncology, liver, and gastrointestinal indications. These services include kitting and logistics management, tissue processing, and staining across H&E, IHC, and special stains. Additionally, PathAI provides access to its extensive network of more than 500 board-certified pathologists. PathAI provides a comprehensive and streamlined approach to controlled clinical trials by consolidating these services in a single facility.

Ibex Raises USD 55 Million in Series C Funding to Drive Global Adoption of AI for Cancer Diagnosis

Ibex Medical Analytics, a company in AI-powered cancer diagnostics, completed a Series C financing round, securing USD 55 million in funding. This latest round was led by 83North and other investors, bringing the total funding since Ibex's establishment in 2016 to approximately USD 100 million. The funds raised are to be utilized to expand Ibex's presence in the United States and accelerate the growth of its product portfolio. This investment underlines the commercial momentum achieved by Ibex and demonstrates their commitment to pursuing future opportunities in tissue diagnostics.

Quest Diagnostics Launches Novel Prostate Cancer Test Aimed at Improving Diagnosis and Grading

Quest Diagnostics introduced a groundbreaking prostate cancer biomarker test in collaboration with Envision Sciences. This innovative test service aims to fulfill the demand for accurate and distinguishing tests that can identify aggressive cases of prostate cancer.

Key Company Profiles

The report delves into recent significant developments in the Tissue Diagnostics Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Abcam Plc, Agilent Technologies, Inc., Atlas Antibodies AB, Bio-Rad Laboratories, Inc., Bio-Techne Corporation, Biogenex Laboratories Inc., BioIVT, LLC, bioMérieux SA, Cardinal Health, Inc., Castle Biosciences, Inc., Cell Signaling Technology, Inc., Diagnostic BioSystems Inc., F. Hoffmann-La Roche Ltd, Leica Biosystems by Danaher Corporation, McKesson Corporation, Merck KGaA, MILESTONE MEDICAL Srl, PathAI, Inc., Pfizer Inc., PROGEN Biotechnik GmbH, QIAGEN N.V., Quest Diagnostics Incorporated, Sekisui Diagnostics, LLC, Siemens Healthineers AG, SLEE medical GmbH, and Thermo Fisher Scientific Inc.

This research report offers invaluable insights into various crucial aspects of the Tissue Diagnostics Market:

  1. Market Penetration: This section thoroughly overviews the current market landscape, incorporating detailed data from key industry players.
  2. Market Development: The report examines potential growth prospects in emerging markets and assesses expansion opportunities in mature segments.
  3. Market Diversification: This includes detailed information on recent product launches, untapped geographic regions, recent industry developments, and strategic investments.
  4. Competitive Assessment & Intelligence: An in-depth analysis of the competitive landscape is conducted, covering market share, strategic approaches, product range, certifications, regulatory approvals, patent analysis, technology developments, and advancements in the manufacturing capabilities of leading market players.
  5. Product Development & Innovation: This section offers insights into upcoming technologies, research and development efforts, and notable advancements in product innovation.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current market size and projected growth?
  2. Which products, segments, applications, and regions offer promising investment opportunities?
  3. What are the prevailing technology trends and regulatory frameworks?
  4. What is the market share and positioning of the leading vendors?
  5. What revenue sources and strategic opportunities do vendors in the market consider when deciding to enter or exit?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing incidence of cancer worldwide
5.1.1.2. Growing use of personalized medicine
5.1.1.3. Government initiatives to increase awareness regarding effective and early cancer diagnosis
5.1.2. Restraints
5.1.2.1. High cost involved in tissue diagnosis and reimbursement issues
5.1.3. Opportunities
5.1.3.1. Inception of digital pathology and automated tissue diagnostics
5.1.3.2. Innovative technologies and instruments development in tissue diagnostic field
5.1.4. Challenges
5.1.4.1. Limitations associated with tissue diagnostics procedures coupled with privacy concerns
5.2. Market Segmentation Analysis
5.2.1. Product: Proliferating use of tissue-processing systems for efficient processing and analyzing diagnosing tissue samples
5.2.2. Technology: Adoption of digital pathology technology for the management of digitized histological samples through computer technology
5.2.3. Indications: Exponential use of tissue diagnostics in the detection and characterization of numerous cancer types
5.2.4. End-User: Significant utilization of tissue diagnostics in clinical pathology laboratories to improve patient care quality
5.3. Market Trend Analysis
5.3.1. Significant emphasis on securing approvals for tissue diagnostic technologies in the Americas
5.3.2. Government initiatives to encourage early detection and screening of chronic diseases in the APAC region
5.3.3. Revolutionary advancements in tissue diagnostic technologies in the EMEA region
5.4. Cumulative Impact of Russia-Ukraine Conflict
5.5. Cumulative Impact of High Inflation
5.6. Porter’s Five Forces Analysis
5.6.1. Threat of New Entrants
5.6.2. Threat of Substitutes
5.6.3. Bargaining Power of Customers
5.6.4. Bargaining Power of Suppliers
5.6.5. Industry Rivalry
5.7. Value Chain & Critical Path Analysis
5.8. Regulatory Framework Analysis
6. Tissue Diagnostics Market, by Product
6.1. Introduction
6.2. Accessories
6.3. Consumables
6.4. Instruments
6.5. Software
7. Tissue Diagnostics Market, by Technology
7.1. Introduction
7.2. Digital Pathology & Workflow
7.3. Immunohistochemistry
7.4. In Situ Hybridization
7.5. Special Staining
8. Tissue Diagnostics Market, by Indications
8.1. Introduction
8.2. Breast Cancer
8.3. Gastric Cancer
8.4. Lymphoma
8.5. Non Small Cell Lung Cancer
8.6. Prostate Cancer
9. Tissue Diagnostics Market, by End-User
9.1. Introduction
9.2. Clinical Pathology
9.3. Contract Research Organization
9.4. Hospitals
9.5. Pharmaceutical Organizations
9.6. Research Laboratories
10. Americas Tissue Diagnostics Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Tissue Diagnostics Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Tissue Diagnostics Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. Market Share Analysis, 2023
13.2. FPNV Positioning Matrix, 2023
13.3. Competitive Scenario Analysis
13.3.1. PathAI Announces Expansion of BioPharma Lab to Provide End-to-End Central Pathology and Histology Services
13.3.2. Ibex Raises USD 55 Million in Series C Funding to Drive Global Adoption of AI for Cancer Diagnosis
13.3.3. Quest Diagnostics Launches Novel Prostate Cancer Test Aimed at Improving Diagnosis and Grading
13.3.4. Cytelabs expanding diagnostic services to hospitals and patients across south India
13.3.5. Bio-Techne Buys Lunaphore to Boost Cancer Diagnostics Through Spatial Biology
13.3.6. Lunaphore Secures Chf 40 Million to Boost Portfolio of Tissue Diagnostics Solutions
13.3.7. Launch of Optimer-Fc as a New Reagent Solution for Immunohistochemistry
13.3.8. Ibex and Alverno Laboratories Sign Multi-Year, Multi-Tissue Expansion Agreement of AI for Cancer Diagnosis
13.3.9. Roche Expands Collaboration with Janssen to Advance Personalized Healthcare Through Companion Diagnostics
13.3.10. Guardant Health to Integrate Lunit's Ai-Based Scoring Algorithm for Pd-L1 into its Portfolio to Enhance Cancer Biomarker Detection
13.3.11. Epredia and Aiforia Join RegenMed Hub Innovation Accelerator, Expanding PHC Group Presence in Regenerative Medicine Partnership Will Pave the Way for New RegenMed Clinical Trials Catalyst Program
13.3.12. Microsoft Strikes Partnership with Paige to Advance Cancer Diagnostics and Treatment
13.3.13. Agilent and Akoya Biosciences Announce Partnership to Drive Multiplex Tissue Assay Development for Biopharma Applications
13.3.14. Tempus Receives U.S. FDA Approval for xT CDx, a NGS-Based In Vitro Diagnostic Device
13.3.15. ROCHE tissue diagnostics celebrates marana expansion project
14. Competitive Portfolio
14.1. Key Company Profiles
14.2. Key Product Portfolio
List of Figures
FIGURE 1. TISSUE DIAGNOSTICS MARKET RESEARCH PROCESS
FIGURE 2. TISSUE DIAGNOSTICS MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. TISSUE DIAGNOSTICS MARKET DYNAMICS
FIGURE 7. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 8. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
FIGURE 10. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY INDICATIONS, 2023 VS 2030 (%)
FIGURE 12. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY INDICATIONS, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 14. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS TISSUE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 16. AMERICAS TISSUE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES TISSUE DIAGNOSTICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 18. UNITED STATES TISSUE DIAGNOSTICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC TISSUE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC TISSUE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA TISSUE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA TISSUE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 23. TISSUE DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 24. TISSUE DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. TISSUE DIAGNOSTICS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, 2018-2023 (USD MILLION)
TABLE 4. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, 2024-2030 (USD MILLION)
TABLE 5. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
TABLE 6. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
TABLE 7. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 8. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 9. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY ACCESSORIES, BY REGION, 2018-2023 (USD MILLION)
TABLE 10. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY ACCESSORIES, BY REGION, 2024-2030 (USD MILLION)
TABLE 11. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2023 (USD MILLION)
TABLE 12. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, BY REGION, 2024-2030 (USD MILLION)
TABLE 13. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2023 (USD MILLION)
TABLE 14. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2024-2030 (USD MILLION)
TABLE 15. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY ANTIBODIES, BY REGION, 2018-2023 (USD MILLION)
TABLE 16. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY ANTIBODIES, BY REGION, 2024-2030 (USD MILLION)
TABLE 17. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY KITS, BY REGION, 2018-2023 (USD MILLION)
TABLE 18. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY KITS, BY REGION, 2024-2030 (USD MILLION)
TABLE 19. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY PROBES, BY REGION, 2018-2023 (USD MILLION)
TABLE 20. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY PROBES, BY REGION, 2024-2030 (USD MILLION)
TABLE 21. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY REAGENTS, BY REGION, 2018-2023 (USD MILLION)
TABLE 22. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY REAGENTS, BY REGION, 2024-2030 (USD MILLION)
TABLE 23. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2023 (USD MILLION)
TABLE 24. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, BY REGION, 2024-2030 (USD MILLION)
TABLE 25. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
TABLE 26. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
TABLE 27. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY SCANNERS, BY REGION, 2018-2023 (USD MILLION)
TABLE 28. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY SCANNERS, BY REGION, 2024-2030 (USD MILLION)
TABLE 29. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY SLIDE-STAINING SYSTEMS, BY REGION, 2018-2023 (USD MILLION)
TABLE 30. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY SLIDE-STAINING SYSTEMS, BY REGION, 2024-2030 (USD MILLION)
TABLE 31. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY TISSUE MICROARRAYS, BY REGION, 2018-2023 (USD MILLION)
TABLE 32. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY TISSUE MICROARRAYS, BY REGION, 2024-2030 (USD MILLION)
TABLE 33. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY TISSUE-PROCESSING SYSTEMS, BY REGION, 2018-2023 (USD MILLION)
TABLE 34. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY TISSUE-PROCESSING SYSTEMS, BY REGION, 2024-2030 (USD MILLION)
TABLE 35. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2023 (USD MILLION)
TABLE 36. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY SOFTWARE, BY REGION, 2024-2030 (USD MILLION)
TABLE 37. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 38. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 39. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY DIGITAL PATHOLOGY & WORKFLOW, BY REGION, 2018-2023 (USD MILLION)
TABLE 40. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY DIGITAL PATHOLOGY & WORKFLOW, BY REGION, 2024-2030 (USD MILLION)
TABLE 41. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, BY REGION, 2018-2023 (USD MILLION)
TABLE 42. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, BY REGION, 2024-2030 (USD MILLION)
TABLE 43. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY IN SITU HYBRIDIZATION, BY REGION, 2018-2023 (USD MILLION)
TABLE 44. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY IN SITU HYBRIDIZATION, BY REGION, 2024-2030 (USD MILLION)
TABLE 45. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY SPECIAL STAINING, BY REGION, 2018-2023 (USD MILLION)
TABLE 46. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY SPECIAL STAINING, BY REGION, 2024-2030 (USD MILLION)
TABLE 47. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY INDICATIONS, 2018-2023 (USD MILLION)
TABLE 48. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY INDICATIONS, 2024-2030 (USD MILLION)
TABLE 49. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY BREAST CANCER, BY REGION, 2018-2023 (USD MILLION)
TABLE 50. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY BREAST CANCER, BY REGION, 2024-2030 (USD MILLION)
TABLE 51. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY GASTRIC CANCER, BY REGION, 2018-2023 (USD MILLION)
TABLE 52. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY GASTRIC CANCER, BY REGION, 2024-2030 (USD MILLION)
TABLE 53. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY LYMPHOMA, BY REGION, 2018-2023 (USD MILLION)
TABLE 54. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY LYMPHOMA, BY REGION, 2024-2030 (USD MILLION)
TABLE 55. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY NON SMALL CELL LUNG CANCER, BY REGION, 2018-2023 (USD MILLION)
TABLE 56. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY NON SMALL CELL LUNG CANCER, BY REGION, 2024-2030 (USD MILLION)
TABLE 57. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY PROSTATE CANCER, BY REGION, 2018-2023 (USD MILLION)
TABLE 58. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY PROSTATE CANCER, BY REGION, 2024-2030 (USD MILLION)
TABLE 59. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 60. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 61. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY CLINICAL PATHOLOGY, BY REGION, 2018-2023 (USD MILLION)
TABLE 62. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY CLINICAL PATHOLOGY, BY REGION, 2024-2030 (USD MILLION)
TABLE 63. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATION, BY REGION, 2018-2023 (USD MILLION)
TABLE 64. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATION, BY REGION, 2024-2030 (USD MILLION)
TABLE 65. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2023 (USD MILLION)
TABLE 66. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY HOSPITALS, BY REGION, 2024-2030 (USD MILLION)
TABLE 67. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY PHARMACEUTICAL ORGANIZATIONS, BY REGION, 2018-2023 (USD MILLION)
TABLE 68. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY PHARMACEUTICAL ORGANIZATIONS, BY REGION, 2024-2030 (USD MILLION)
TABLE 69. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY RESEARCH LABORATORIES, BY REGION, 2018-2023 (USD MILLION)
TABLE 70. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY RESEARCH LABORATORIES, BY REGION, 2024-2030 (USD MILLION)
TABLE 71. AMERICAS TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 72. AMERICAS TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 73. AMERICAS TISSUE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2023 (USD MILLION)
TABLE 74. AMERICAS TISSUE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2024-2030 (USD MILLION)
TABLE 75. AMERICAS TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
TABLE 76. AMERICAS TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
TABLE 77. AMERICAS TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 78. AMERICAS TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 79. AMERICAS TISSUE DIAGNOSTICS MARKET SIZE, BY INDICATIONS, 2018-2023 (USD MILLION)
TABLE 80. AMERICAS TISSUE DIAGNOSTICS MARKET SIZE, BY INDICATIONS, 2024-2030 (USD MILLION)
TABLE 81. AMERICAS TISSUE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 82. AMERICAS TISSUE DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 83. AMERICAS TISSUE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 84. AMERICAS TISSUE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 85. ARGENTINA TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 86. ARGENTINA TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 87. ARGENTINA TISSUE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2023 (USD MILLION)
TABLE 88. ARGENTINA TISSUE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2024-2030 (USD MILLION)
TABLE 89. ARGENTINA TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
TABLE 90. ARGENTINA TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
TABLE 91. ARGENTINA TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 92. ARGENTINA TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 93. ARGENTINA TISSUE DIAGNOSTICS MARKET SIZE, BY INDICATIONS, 2018-2023 (USD MILLION)
TABLE 94. ARGENTINA TISSUE DIAGNOSTICS MARKET SIZE, BY INDICATIONS, 2024-2030 (USD MILLION)
TABLE 95. ARGENTINA TISSUE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 96. ARGENTINA TISSUE DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 97. BRAZIL TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 98. BRAZIL TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 99. BRAZIL TISSUE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2023 (USD MILLION)
TABLE 100. BRAZIL TISSUE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2024-2030 (USD MILLION)
TABLE 101. BRAZIL TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
TABLE 102. BRAZIL TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
TABLE 103. BRAZIL TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 104. BRAZIL TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 105. BRAZIL TISSUE DIAGNOSTICS MARKET SIZE, BY INDICATIONS, 2018-2023 (USD MILLION)
TABLE 106. BRAZIL TISSUE DIAGNOSTICS MARKET SIZE, BY INDICATIONS, 2024-2030 (USD MILLION)
TABLE 107. BRAZIL TISSUE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 108. BRAZIL TISSUE DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 109. CANADA TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 110. CANADA TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 111. CANADA TISSUE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2023 (USD MILLION)
TABLE 112. CANADA TISSUE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2024-2030 (USD MILLION)
TABLE 113. CANADA TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
TABLE 114. CANADA TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
TABLE 115. CANADA TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 116. CANADA TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 117. CANADA TISSUE DIAGNOSTICS MARKET SIZE, BY INDICATIONS, 2018-2023 (USD MILLION)
TABLE 118. CANADA TISSUE DIAGNOSTICS MARKET SIZE, BY INDICATIONS, 2024-2030 (USD MILLION)
TABLE 119. CANADA TISSUE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 120. CANADA TISSUE DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 121. MEXICO TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 122. MEXICO TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 123. MEXICO TISSUE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2023 (USD MILLION)
TABLE 124. MEXICO TISSUE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2024-2030 (USD MILLION)
TABLE 125. MEXICO TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
TABLE 126. MEXICO TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
TABLE 127. MEXICO TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 128. MEXICO TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 129. MEXICO TISSUE DIAGNOSTICS MARKET SIZE, BY INDICATIONS, 2018-2023 (USD MILLION)
TABLE 130. MEXICO TISSUE DIAGNOSTICS MARKET SIZE, BY INDICATIONS, 2024-2030 (USD MILLION)
TABLE 131. MEXICO TISSUE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 132. MEXICO TISSUE DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 133. UNITED STATES TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 134. UNITED STATES TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 135. UNITED STATES TISSUE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2023 (USD MILLION)
TABLE 136. UNITED STATES TISSUE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2024-2030 (USD MILLION)
TABLE 137. UNITED STATES TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
TABLE 138. UNITED STATES TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
TABLE 139. UNITED STATES TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 140. UNITED STATES TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 141. UNITED STATES TISSUE DIAGNOSTICS MARKET SIZE, BY INDICATIONS, 2018-2023 (USD MILLION)
TABLE 142. UNITED STATES TISSUE DIAGNOSTICS MARKET SIZE, BY INDICATIONS, 2024-2030 (USD MILLION)
TABLE 143. UNITED STATES TISSUE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 144. UNITED STATES TISSUE DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 145. UNITED STATES TISSUE DIAGNOSTICS MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
TABLE 146. UNITED STATES TISSUE DIAGNOSTICS MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
TABLE 147. ASIA-PACIFIC TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 148. ASIA-PACIFIC TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 149. ASIA-PACIFIC TISSUE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2023 (USD MILLION)
TABLE 150. ASIA-PACIFIC TISSUE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2024-2030 (USD MILLION)
TABLE 151. ASIA-PACIFIC TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
TABLE 152. ASIA-PACIFIC TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
TABLE 153. ASIA-PACIFIC TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 154. ASIA-PACIFIC TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 155. ASIA-PACIFIC TISSUE DIAGNOSTICS MARKET SIZE, BY INDICATIONS, 2018-2023 (USD MILLION)
TABLE 156. ASIA-PACIFIC TISSUE DIAGNOSTICS MARKET SIZE, BY INDICATIONS, 2024-2030 (USD MILLION)
TABLE 157. ASIA-PACIFIC TISSUE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 158. ASIA-PACIFIC TISSUE DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 159. ASIA-PACIFIC TISSUE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 160. ASIA-PACIFIC TISSUE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 161. AUSTRALIA TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 162. AUSTRALIA TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 163. AUSTRALIA TISSUE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2023 (USD MILLION)
TABLE 164. AUSTRALIA TISSUE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2024-2030 (USD MILLION)
TABLE 165. AUSTRALIA TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
TABLE 166. AUSTRALIA TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
TABLE 167. AUSTRALIA TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 168. AUSTRALIA TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 169. AUSTRALIA TISSUE DIAGNOSTICS MARKET SIZE, BY INDICATIONS, 2018-2023 (USD MILLION)
TABLE 170. AUSTRALIA TISSUE DIAGNOSTICS MARKET SIZE, BY INDICATIONS, 2024-2030 (USD MILLION)
TABLE 171. AUSTRALIA TISSUE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 172. AUSTRALIA TISSUE DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 173. CHINA TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 174. CHINA TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 175. CHINA TISSUE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2023 (USD MILLION)
TABLE 176. CHINA TISSUE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2024-2030 (USD MILLION)
TABLE 177. CHINA TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
TABLE 178. CHINA TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
TABLE 179. CHINA TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 180. CHINA TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 181. CHINA TISSUE DIAGNOSTICS MARKET SIZE, BY INDICATIONS, 2018-2023 (USD MILLION)
TABLE 182. CHINA TISSUE DIAGNOSTICS MARKET SIZE, BY INDICATIONS, 2024-2030 (USD MILLION)
TABLE 183. CHINA TISSUE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 184. CHINA TISSUE DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 185. INDIA TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 186. INDIA TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 187. INDIA TISSUE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2023 (USD MILLION)
TABLE 188. INDIA TISSUE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2024-2030 (USD MILLION)
TABLE 189. INDIA TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
TABLE 190. INDIA TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
TABLE 191. INDIA TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 192. INDIA TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 193. INDIA TISSUE DIAGNOSTICS MARKET SIZE, BY INDICATIONS, 2018-2023 (USD MILLION)
TABLE 194. INDIA TISSUE DIAGNOSTICS MARKET SIZE, BY INDICATIONS, 2024-2030 (USD MILLION)
TABLE 195. INDIA TISSUE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 196. INDIA TISSUE DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 197. INDONESIA TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 198. INDONESIA TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 199. INDONESIA TISSUE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2023 (USD MILLION)
TABLE 200. INDONESIA TISSUE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2024-2030 (USD MILLION)
TABLE 201. INDONESIA TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
TABLE 202. INDONESIA TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
TABLE 203. INDONESIA TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 204. INDONESIA TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 205. INDONESIA TISSUE DIAGNOSTICS MARKET SIZE, BY INDICATIONS, 2018-2023 (USD MILLION)
TABLE 206. INDONESIA TISSUE DIAGNOSTICS MARKET SIZE, BY INDICATIONS, 2024-2030 (USD MILLION)
TABLE 207. INDONESIA TISSUE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 208. INDONESIA TISSUE DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 209. JAPAN TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 210. JAPAN TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 211. JAPAN TISSUE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2023 (USD MILLION)
TABLE 212. JAPAN TISSUE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2024-2030 (USD MILLION)
TABLE 213. JAPAN TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
TABLE 214. JAPAN TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
TABLE 215. JAPAN TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 216. JAPAN TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 217. JAPAN TISSUE DIAGNOSTICS MARKET SIZE, BY INDICATIONS, 2018-2023 (USD MILLION)
TABLE 218. JAPAN TISSUE DIAGNOSTICS MARKET SIZE, BY INDICATIONS, 2024-2030 (USD MILLION)
TABLE 219. JAPAN TISSUE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 220. JAPAN TISSUE DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 221. MALAYSIA TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 222. MALAYSIA TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 223. MALAYSIA TISSUE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2023 (USD MILLION)
TABLE 224. MALAYSIA TISSUE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2024-2030 (USD MILLION)
TABLE 225. MALAYSIA TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
TABLE 226. MALAYSIA TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
TABLE 227. MALAYSIA TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 228. MALAYSIA TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 229. MALAYSIA TISSUE DIAGNOSTICS MARKET SIZE, BY INDICATIONS, 2018-2023 (USD MILLION)
TABLE 230. MALAYSIA TISSUE DIAGNOSTICS MARKET SIZE, BY INDICATIONS, 2024-2030 (USD MILLION)
TABLE 231. MALAYSIA TISSUE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 232. MALAYSIA TISSUE DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 233. PHILIPPINES TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 234. PHILIPPINES TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 235. PHILIPPINES TISSUE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2023 (USD MILLION)
TABLE 236. PHILIPPINES TISSUE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2024-2030 (USD MILLION)
TABLE 237. PHILIPPINES TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
TABLE 238. PHILIPPINES TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
TABLE 239. PHILIPPINES TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 240. PHILIPPINES TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 241. PHILIPPINES TISSUE DIAGNOSTICS MARKET SIZE, BY INDICATIONS, 2018-2023 (USD MILLION)
TABLE 242. PHILIPPINES TISSUE DIAGNOSTICS MARKET SIZE, BY INDICATIONS, 2024-2030 (USD MILLION)
TABLE 243. PHILIPPINES TISSUE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 244. PHILIPPINES TISSUE DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 245. SINGAPORE TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 246. SINGAPORE TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 247. SINGAPORE TISSUE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2023 (USD MILLION)
TABLE 248. SINGAPORE TISSUE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2024-2030 (USD MILLION)
TABLE 249. SINGAPORE TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
TABLE 250. SINGAPORE TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
TABLE 251. SINGAPORE TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 252. SINGAPORE TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 253. SINGAPORE TISSUE DIAGNOSTICS MARKET SIZE, BY INDICATIONS, 2018-2023 (USD MILLION)
TABLE 254. SINGAPORE TISSUE DIAGNOSTICS MARKET SIZE, BY INDICATIONS, 2024-2030 (USD MILLION)
TABLE 255. SINGAPORE TISSUE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 256. SINGAPORE TISSUE DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 257. SOUTH KOREA TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 258. SOUTH KOREA TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 259. SOUTH KOREA TISSUE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2023 (USD MILLION)
TABLE 260. SOUTH KOREA TISSUE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2024-2030 (USD MILLION)
TABLE 261. SOUTH KOREA TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
TABLE 262. SOUTH KOREA TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
TABLE 263. SOUTH KOREA TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 264. SOUTH KOREA TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 265. SOUTH KOREA TISSUE DIAGNOSTICS MARKET SIZE, BY INDICATIONS, 2018-2023 (USD MILLION)
TABLE 266. SOUTH KOREA TISSUE DIAGNOSTICS MARKET SIZE, BY INDICATIONS, 2024-2030 (USD MILLION)
TABLE 267. SOUTH KOREA TISSUE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 268. SOUTH KOREA TISSUE DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 269. TAIWAN TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 270. TAIWAN TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 271. TAIWAN TISSUE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2023 (USD MILLION)
TABLE 272. TAIWAN TISSUE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2024-2030 (USD MILLION)
TABLE 273. TAIWAN TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
TABLE 274. TAIWAN TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
TABLE 275. TAIWAN TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 276. TAIWAN TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 277. TAIWAN TISSUE DIAGNOSTICS MARKET SIZE, BY INDICATIONS, 2018-2023 (USD MILLION)
TABLE 278. TAIWAN TISSUE DIAGNOSTICS MARKET SIZE, BY INDICATIONS, 2024-2030 (USD MILLION)
TABLE 279. TAIWAN TISSUE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 280. TAIWAN TISSUE DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 281. THAILAND TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 282. THAILAND TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 283. THAILAND TISSUE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2023 (USD MILLION)
TABLE 284. THAILAND TISSUE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2024-2030 (USD MILLION)
TABLE 285. THAILAND TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
TABLE 286. THAILAND TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
TABLE 287. THAILAND TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 288. THAILAND TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 289. THAILAND TISSUE DIAGNOSTICS MARKET SIZE, BY INDICATIONS, 2018-2023 (USD MILLION)
TABLE 290. THAILAND TISSUE DIAGNOSTICS MARKET SIZE, BY INDICATIONS, 2024-2030 (USD MILLION)
TABLE 291. THAILAND TISSUE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 292. THAILAND TISSUE DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 293. VIETNAM TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 294. VIETNAM TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 295. VIETNAM TISSUE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2023 (USD MILLION)
TABLE 296. VIETNAM TISSUE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2024-2030 (USD MILLION)
TABLE 297. VIETNAM TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
TABLE 298. VIETNAM TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
TABLE 299. VIETNAM TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 300. VIETNAM TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 301. VIETNAM TISSUE DIAGNOSTICS MARKET SIZE, BY INDICATIONS, 2018-2023 (USD MILLION)
TABLE 302. VIETNAM TISSUE DIAGNOSTICS MARKET SIZE, BY INDICATIONS, 2024-2030 (USD MILLION)
TABLE 303. VIETNAM TISSUE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 304. VIETNAM TISSUE DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 305. EUROPE, MIDDLE EAST & AFRICA TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 306. EUROPE, MIDDLE EAST & AFRICA TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 307. EUROPE, MIDDLE EAST & AFRICA TISSUE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2023 (USD MILLION)
TABLE 308. EUROPE, MIDDLE EAST & AFRICA TISSUE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2024-2030 (USD MILLION)
TABLE 309. EUROPE, MIDDLE EAST & AFRICA TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
TABLE 310. EUROPE, MIDDLE EAST & AFRICA TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
TABLE 311. EUROPE, MIDDLE EAST & AFRICA TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 312. EUROPE, MIDDLE EAST & AFRICA TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 313. EUROPE, MIDDLE EAST & AFRICA TISSUE DIAGNOSTICS MARKET SIZE, BY INDICATIONS, 2018-2023 (USD MILLION)
TABLE 314. EUROPE, MIDDLE EAST & AFRICA TISSUE DIAGNOSTICS MARKET SIZE, BY INDICATIONS, 2024-2030 (USD MILLION)
TABLE 315. EUROPE, MIDDLE EAST & AFRICA TISSUE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 316. EUROPE, MIDDLE EAST & AFRICA TISSUE DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 317. EUROPE, MIDDLE EAST & AFRICA TISSUE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 318. EUROPE, MIDDLE EAST & AFRICA TISSUE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 319. DENMARK TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 320. DENMARK TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 321. DENMARK TISSUE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2023 (USD MILLION)
TABLE 322. DENMARK TISSUE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2024-2030 (USD MILLION)
TABLE 323. DENMARK TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
TABLE 324. DENMARK TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
TABLE 325. DENMARK TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 326. DENMARK TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 327. DENMARK TISSUE DIAGNOSTICS MARKET SIZE, BY INDICATIONS, 2018-2023 (USD MILLION)
TABLE 328. DENMARK TISSUE DIAGNOSTICS MARKET SIZE, BY INDICATIONS, 2024-2030 (USD MILLION)
TABLE 329. DENMARK TISSUE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 330. DENMARK TISSUE DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 331. EGYPT TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 332. EGYPT TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 333. EGYPT TISSUE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2023 (USD MILLION)
TABLE 334. EGYPT TISSUE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2024-2030 (USD MILLION)
TABLE 335. EGYPT TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
TABLE 336. EGYPT TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
TABLE 337. EGYPT TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 338. EGYPT TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 339. EGYPT TISSUE DIAGNOSTICS MARKET SIZE, BY INDICATIONS, 2018-2023 (USD MILLION)
TABLE 340. EGYPT TISSUE DIAGNOSTICS MARKET SIZE, BY INDICATIONS, 2024-2030 (USD MILLION)
TABLE 341. EGYPT TISSUE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 342. EGYPT TISSUE DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 343. FINLAND TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 344. FINLAND TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 345. FINLAND TISSUE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2023 (USD MILLION)
TABLE 346. FINLAND TISSUE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2024-2030 (USD MILLION)
TABLE 347. FINLAND TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
TABLE 348. FINLAND TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
TABLE 349. FINLAND TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 350. FINLAND TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 351. FINLAND TISSUE DIAGNOSTICS MARKET SIZE, BY INDICATIONS, 2018-2023 (USD MILLION)
TABLE 352. FINLAND TISSUE DIAGNOSTICS MARKET SIZE, BY INDICATIONS, 2024-2030 (USD MILLION)
TABLE 353. FINLAND TISSUE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (US

Companies Mentioned

  • Abbott Laboratories
  • Abcam Plc
  • Agilent Technologies, Inc.
  • Atlas Antibodies AB
  • Bio-Rad Laboratories, Inc.
  • Bio-Techne Corporation
  • Biogenex Laboratories Inc.
  • BioIVT, LLC
  • bioMérieux SA
  • Cardinal Health, Inc.
  • Castle Biosciences, Inc.
  • Cell Signaling Technology, Inc.
  • Diagnostic BioSystems Inc.
  • F. Hoffmann-La Roche Ltd
  • Leica Biosystems by Danaher Corporation
  • McKesson Corporation
  • Merck KGaA
  • MILESTONE MEDICAL Srl
  • PathAI, Inc.
  • Pfizer Inc.
  • PROGEN Biotechnik GmbH
  • QIAGEN N.V.
  • Quest Diagnostics Incorporated
  • Sekisui Diagnostics, LLC
  • Siemens Healthineers AG
  • SLEE medical GmbH
  • Thermo Fisher Scientific Inc.

Methodology

Loading
LOADING...

Table Information